Brand names
Insulin glargine and Lixisenatide brand names
1 brands in 1 markets
Insulin glargine and Lixisenatide is sold under 1 brand names in 1 markets in our register data, including Soliqua 100/33. The table shows the market, marketing authorisation holder, strengths and forms for each brand, with the register it comes from.
| Brand | Market | Marketing authorisation holder | Strengths and forms | Source |
|---|---|---|---|---|
| Soliqua 100/33 | United States | Sanofi-Aventis | 100 units/33 mcg per mLInjection | US FDA NDC directoryChecked 12 November 2026 |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Insulin glargine and Lixisenatide for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.